Author

K. Dijkman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Aagaard· 1 shared C. Carvalho dos Santos· 1 shared C. G. Engele· 1 shared C. J. Korbee· 1 shared C. S. Lindestam Arlehamn· 1 shared F. A. Verreck· 1 shared F. Vrieling· 1 shared H. Battey· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Aagaard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

M. T. Heemskerk, C. J. Korbee, J. Esselink, C. Carvalho dos Santos, S. van Veen, I. F. Gordijn, F. Vrieling, K. V. Walburg, C. G. Engele, K. Dijkman, L. Wilson, F. A. Verreck, M. C. Haks, T. H. Ottenhoff

This study identifies two antipsychotic drugs, Pimozide and Fluspirilene, as potential host-directed therapies for Mycobacterium tuberculosis and Salmonella enterica infections by modulating autophagy and lysosomal responses.

bioRxiv · Jun 5, 2021Immunology

A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin

J. S. Woodworth, H. Strand Clemmensen, H. Battey, K. Dijkman, T. Lindenstrom, R. Salvador Laureano, R. Taplitz, J. Morgan, C. Aagaard, I. Rosenkrands, C. S. Lindestam Arlehamn, P. Andersen, R. Mortensen

This study develops a Mycobacterium tuberculosis-specific subunit vaccine, H107, which when co-administered with BCG enhances immune responses and provides better protection than either vaccine alone.

bioRxiv · Mar 18, 2021Immunology